- Previous Close
7.84 - Open
7.94 - Bid 8.24 x --
- Ask 8.25 x --
- Day's Range
7.85 - 8.54 - 52 Week Range
3.84 - 12.85 - Volume
597,621 - Avg. Volume
613,801 - Market Cap (intraday)
450.405M - Beta (5Y Monthly) 2.71
- PE Ratio (TTM)
-- - EPS (TTM)
-0.63 - Earnings Date Nov 6, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
9.50
Aurora Cannabis Inc., together with its subsidiaries, engages in the production, distribution, and sale of cannabis and cannabis-derivative products in Canada and internationally. It operates through two segments, Canadian Cannabis and Plant Propagation. The company offers medical and consumer cannabis products; supplies propagated vegetables and ornamental plants; and distributes and sells hemp-derived cannabidiol (CBD) products. The company also cultivates and sells dried cannabis, cannabis oils, capsules, edible cannabis, cannabis extracts, and soft gels, which are ingested in various ways, including smoking, vaporizing, and consumption in the form of oil, capsules, dried flowers, vapes, dried milled strains, edibles, concentrates, and strain specific cannabis oils and extracts; and provides patient counseling and outreach services. Its adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard, as well as CBD brands, Reliva and KG7; and medical cannabis brands include MedReleaf, CanniMed, Aurora, Whistler Medical Marijuana Co, Pedanios, Bidiol, and CraftPlant. The company was founded in 2013 and is headquartered in Edmonton, Canada.
www.auroramj.com1,073
Full Time Employees
March 31
Fiscal Year Ends
Healthcare
Sector
Drug Manufacturers - Specialty & Generic
Industry
Recent News: ACB.TO
View More
Performance Overview: ACB.TO
Trailing total returns as of 2024-10-25, which may include dividends or other distributions. Benchmark is
.YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: ACB.TO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: ACB.TO
View MoreValuation Measures
Market Cap
450.40M
Enterprise Value
437.02M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.61
Price/Book (mrq)
0.80
Enterprise Value/Revenue
1.57
Enterprise Value/EBITDA
56.00
Financial Highlights
Profitability and Income Statement
Profit Margin
-11.53%
Return on Assets (ttm)
-1.87%
Return on Equity (ttm)
-6.13%
Revenue (ttm)
278.98M
Net Income Avi to Common (ttm)
-30.32M
Diluted EPS (ttm)
-0.63
Balance Sheet and Cash Flow
Total Cash (mrq)
115.49M
Total Debt/Equity (mrq)
16.95%
Levered Free Cash Flow (ttm)
-106.21M